Heart failure (HF) is a complex clinical syndrome affecting roughly 26 million people worldwide. Increased sympathetic drive is a hallmark of HF and is associated with disease progression and higher mortality risk. Several mechanisms contribute to enhanced sympathetic activity in HF, but these pathways are still incompletely understood. Previous work suggests that inflammation and activation of the renin-angiotensin system (RAS) increases sympathetic drive. Importantly, chronic inflammation in several brain regions is commonly observed in aged populations, and a growing body of evidence suggests neuroinflammation plays a crucial role in HF. In animal models of HF, central inhibition of RAS and pro-inflammatory cytokines normalizes Hugo S. Díaz H. S. Díaz and others J Physiol 598.1 sympathetic drive and improves cardiac function. The precise molecular and cellular mechanisms that lead to neuroinflammation and its effect on HF progression remain undetermined. This review summarizes the most recent advances in the field of neuroinflammation and autonomic control in HF. In addition, it focuses on cellular and molecular mediators of neuroinflammation in HF and in particular on brain regions involved in sympathetic control. Finally, we will comment on what is known about neuroinflammation in the context of preserved vs. reduced ejection fraction HF.
Abstract figure legendIntegrative physiology of heart failure progression: Heart failure (HF) is characterized by chronic inflammation, renin-angiotensin system (RAS) overactivity, sympathoexcitation and cardiac dysfunction. Sympathoexcitation and RAS activation occur early in HF progression as a compensatory response to haemodynamic challenges. Chronic activation of these compensatory mechanisms becomes maladaptive and has toxic effects on cardiac muscle leading to electrophysiological abnormalities and initiation of fibrotic processes. RAS activation also enhances chemoreflex sensitivity (further exacerbating sympathetic activation) and promotes diffuse inflammation. Both systemic and brain RAS and inflammation feed back to exacerbate sympathoexcitation, generating a vicious cycle that contributes to further cardiac dysfunction.